Syndromic Multiplex Diagnostics Market Size, Share & Trends Analysis Report By Type (Respiratory, Gastrointestinal, Central Nervous System), By End Use (Hospitals, Diagnostic Laboratories, Others), By Region And Segment Forecasts, 2025

The global syndromic multiplex diagnostics market size is anticipated to reach USD 3.66 billion by 2030, and it is expected to expand at a CAGR of 3.91% from 2025 - 2030. The market's growth is attributed to factors such as technological advancements in diagnostics technologies, rising prevalence various diseases, growing demand for rapid and accurate diagnostics solutions, and global aging population.

Traditional diagnostic tests often require multiple steps and take longer to deliver results, whereas syndromic multiplex diagnostics offer a comprehensive solution by testing for multiple pathogens simultaneously in a single sample. This capability significantly reduces the time for diagnosis, increasing their demand in various healthcare settings where rapid diagnostics are preferred. Moreover, the high prevalence of various conditions, such as respiratory diseases, gastrointestinal conditions, and others, requiring effective diagnostics solutions further contributes to the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2023, more than 2.4 million instances of syphilis, gonorrhea, and chlamydia were diagnosed and documented in the U.S. This total includes over 209,000 syphilis cases, over 600,000 gonorrhea cases, and more than 1.6 million chlamydia cases. This high prevalence of infectious diseases is expected to fuel the market growth over the forecast period.

Moreover, the increasing R&D efforts by market players are leading to the development of new diagnostics solutions, increasing the availability of multiple diagnostics products for the end users. For instance, in January 2021, Singapore launched the Fortitude SARS-CoV-2 & Flu A/B Test, a multiplex diagnostic kit developed by MiRXES. This test detects and differentiates SARS-CoV-2 and influenza A/B, providing more accurate diagnoses. The kit received Provisional Authorisation from Singapore’s Health Sciences Authority (HSA). The development of such effective solutions offering better results is expected to increase the adoption of these solutions and drive market growth.

The growing demand for Point-of-Care Testing (POCT) also contributes to market growth. With the rise in the demand for rapid diagnosis, especially in remote or underserved regions, multiplex diagnostic systems offer significant advantages by allowing for the simultaneous detection of multiple pathogens or diseases with a single test. Additionally, focuses on improving the healthcare infrastructure in regions such as Asia, Latin America and MEA are encouraging the implementation of integrated diagnostic systems that can provide faster and more accurate results.

Syndromic Multiplex Diagnostics Market Report Highlights

Based on type, the bipolar respiratory segment held the largest market share in 2024. This is attributed to the rising prevalence of various respiratory infections and rising availability of effective diagnostics technologies.
Based on end use, the diagnostics laboratories segment held the largest market share in 2024. This is attributed to the high patient footfall in these facilities and their better accessibility to patients.
Based on region, North America dominated the market and accounted for a 41.85% share in 2024. The syndromic multiplex diagnostics industry in North America is experiencing significant growth driven by the presence of key market players, evolving regulatory landscape, developed healthcare infrastructure, and increasing prevalence of various infectious diseases.

This product will be delivered within 1-3 business days.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights

Chapter 3. Syndromic Multiplex Diagnostics Market Variables, Trends & Scope

3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of infectious diseases
3.2.1.2. Advancements in diagnostics technologies
3.2.1.3. Growing demand for effective diagnostics solutions
3.2.2. Market restraint analysis
3.2.2.1. High cost of syndromic diagnostics solutions
3.3. Syndromic Multiplex Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis

Chapter 4. Syndromic Multiplex Diagnostics Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Syndromic Multiplex Diagnostics Market: Type Movement Analysis
4.3. Syndromic Multiplex Diagnostics Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Respiratory
4.4.1. Respiratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Gastrointestinal
4.5.1. Gastrointestinal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Central Nervous System
4.6.1. Central Nervous System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Other Types of Syndromes (cUTI and STDs)
4.7.1. Other Types of Syndromes (cUTI and STDs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Syndromic Multiplex Diagnostics Market: End Use Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Syndromic Multiplex Diagnostics Market: End Use Movement Analysis
5.3. Syndromic Multiplex Diagnostics Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Diagnostic Laboratories
5.5.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Syndromic Multiplex Diagnostics Market: Regional Estimates & Trend Analysis

6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/Reimbursement
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/Reimbursement
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/Reimbursement
6.5.3.3. Competitive scenario
6.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/Reimbursement
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/Reimbursement
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/Reimbursement
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/Reimbursement
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/Reimbursement
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/Reimbursement
6.6.6.3. Competitive scenario
6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/Reimbursement
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/Reimbursement
6.6.8.3. Competitive scenario
6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/Reimbursement
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/Reimbursement
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/Reimbursement
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/Reimbursement
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/Reimbursement
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/Reimbursement
6.7.6.3. Competitive scenario
6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/Reimbursement
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Argentina
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/Reimbursement
6.8.2.3. Competitive scenario
6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/Reimbursement
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/Reimbursement
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/Reimbursement
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Abbott Laboratories
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Services benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Thermo Fisher Scientific, Inc.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Services benchmarking
7.3.5.4. Strategic initiatives
7.3.6. F. Hoffmann-La Roche Ltd
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Services benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Qiagen
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Services benchmarking
7.3.7.4. Strategic initiatives
7.3.8. bioMérieux
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Services benchmarking
7.3.8.4. Strategic initiatives
7.3.9. DiaSorin S.p.A (Luminex Corporation)
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Services benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Hologic, Inc.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Services benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Becton, Dickinson and Company (BD)
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Services benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Applied BioCode
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Services benchmarking
7.3.12.4. Strategic initiatives
7.3.13. QIAGEN
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Services benchmarking
7.3.13.4. Strategic initiatives
7.3.14. Curetis GmbH
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Services benchmarking
7.3.14.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 North America syndromic multiplex diagnostics market, by region, 2018 - 2030 (USD Million)
Table 3 North America syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 4 North America syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 5 U.S. syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 6 U.S. syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 7 Canada syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 8 Canada syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 9 Mexico syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 10 Mexico syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 11 Europe syndromic multiplex diagnostics market, by region, 2018 - 2030 (USD Million)
Table 12 Europe syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 13 Europe syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 14 Germany syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 15 Germany syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 16 UK syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 17 UK syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 18 France syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 19 France syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 20 Italy syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 21 Italy syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 22 Spain syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 23 Spain syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 24 Denmark syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 25 Denmark syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 26 Sweden syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 27 Sweden syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 28 Norway syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 29 Norway syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 30 Asia Pacific syndromic multiplex diagnostics market, by region, 2018 - 2030 (USD Million)
Table 31 Asia Pacific syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 32 Asia Pacific syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 33 China syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 34 China syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 35 Japan syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 36 Japan syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 37 India syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 38 India syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 39 South Korea syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 40 South Korea syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 41 Australia syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 42 Australia syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 43 Thailand syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 44 Thailand syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 45 Latin America syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 46 Latin America syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 47 Brazil syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 48 Brazil syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 49 Argentina syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 50 Argentina syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 51 MEA syndromic multiplex diagnostics market, by region, 2018 - 2030 (USD Million)
Table 52 MEA syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 53 MEA syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 54 South Africa syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 55 South Africa syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 56 Saudi Arabia syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 58 UAE syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 59 UAE syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)
Table 60 Kuwait syndromic multiplex diagnostics market, by type, 2018 - 2030 (USD Million)
Table 61 Kuwait syndromic multiplex diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Syndromic multiplex diagnostics market: market outlook
Fig. 14 Syndromic multiplex diagnostics competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Syndromic multiplex diagnostics market driver impact
Fig. 20 Syndromic multiplex diagnostics market restraint impact
Fig. 21 Syndromic multiplex diagnostics market strategic initiatives analysis
Fig. 22 Syndromic multiplex diagnostics market: Type movement analysis
Fig. 23 Syndromic multiplex diagnostics market: Type outlook and key takeaways
Fig. 24 Respiratory market estimates and forecasts, 2018 - 2030
Fig. 25 Gastrointestinal market estimates and forecasts, 2018 - 2030
Fig. 26 Central nervous system market estimates and forecasts, 2018 - 2030
Fig. 27 Other types of syndromes (cUTI and STDs) market estimates and forecasts, 2018 - 2030
Fig. 28 Syndromic multiplex diagnostics market: End Use movement analysis
Fig. 29 Syndromic multiplex diagnostics market: End Use outlook and key takeaways
Fig. 30 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 31 Diagnostic laboratories market estimates and forecasts, 2018 - 2030
Fig. 32 Others market estimates and forecasts, 2018 - 2030
Fig. 33 Global syndromic multiplex diagnostics market: Regional movement analysis
Fig. 34 Global syndromic multiplex diagnostics market: Regional outlook and key takeaways
Fig. 35 Global syndromic multiplex diagnostics market share and leading players
Fig. 36 North America market share and leading players
Fig. 37 Europe market share and leading players
Fig. 38 Asia Pacific market share and leading players
Fig. 39 Latin America market share and leading players
Fig. 40 Middle East & Africa market share and leading players
Fig. 41 North America, by country
Fig. 42 North America
Fig. 43 North America market estimates and forecasts, 2018 - 2030
Fig. 44 U.S. key country dynamics
Fig. 45 U.S. market estimates and forecasts, 2018 - 2030
Fig. 46 Canada country dynamics
Fig. 47 Canada market estimates and forecasts, 2018 - 2030
Fig. 48 Mexico country dynamics
Fig. 49 Mexico market estimates and forecasts, 2018 - 2030
Fig. 50 Europe
Fig. 51 Europe market estimates and forecasts, 2018 - 2030
Fig. 52 UK country dynamics
Fig. 53 UK market estimates and forecasts, 2018 - 2030
Fig. 54 Germany
Fig. 55 Germany market estimates and forecasts, 2018 - 2030
Fig. 56 France country dynamics
Fig. 57 France market estimates and forecasts, 2018 - 2030
Fig. 58 Italy country dynamics
Fig. 59 Italy market estimates and forecasts, 2018 - 2030
Fig. 60 Spain country dynamics
Fig. 61 Spain market estimates and forecasts, 2018 - 2030
Fig. 62 Denmark country dynamics
Fig. 63 Denmark market estimates and forecasts, 2018 - 2030
Fig. 64 Sweden country dynamics
Fig. 65 Sweden market estimates and forecasts, 2018 - 2030
Fig. 66 Norway country dynamics
Fig. 67 Norway market estimates and forecasts, 2018 - 2030
Fig. 68 Asia Pacific
Fig. 69 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 70 China country dynamics
Fig. 71 China market estimates and forecasts, 2018 - 2030
Fig. 72 Japan country dynamics
Fig. 73 Japan market estimates and forecasts, 2018 - 2030
Fig. 74 India country dynamics
Fig. 75 India market estimates and forecasts, 2018 - 2030
Fig. 76 Thailand country dynamics
Fig. 77 Thailand market estimates and forecasts, 2018 - 2030
Fig. 78 South Korea country dynamics
Fig. 79 South Korea market estimates and forecasts, 2018 - 2030
Fig. 80 Australia country dynamics
Fig. 81 Australia market estimates and forecasts, 2018 - 2030
Fig. 82 Latin America
Fig. 83 Latin America market estimates and forecasts, 2018 - 2030
Fig. 84 Brazil country dynamics
Fig. 85 Brazil market estimates and forecasts, 2018 - 2030
Fig. 86 Argentina country dynamics
Fig. 87 Argentina market estimates and forecasts, 2018 - 2030
Fig. 88 Middle East and Africa
Fig. 89 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 90 South Africa country dynamics
Fig. 91 South Africa market estimates and forecasts, 2018 - 2030
Fig. 92 Saudi Arabia country dynamics
Fig. 93 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 94 UAE country dynamics
Fig. 95 UAE market estimates and forecasts, 2018 - 2030
Fig. 96 Kuwait country dynamics
Fig. 97 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 98 Market share of key market players - Syndromic multiplex diagnostics market, 2023
Fig. 99 Company Categorization

Companies Mentioned

Abbott Laboratories
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd
Qiagen
bioMérieux
DiaSorin S.p.A (Luminex Corporation)
Hologic, Inc.
Becton, Dickinson and Company (BD)
Applied BioCode
QIAGEN
Curetis GmbH

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	150
Published	January 2025
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 2.92 Billion
Forecasted Market Value ( USD ) by 2030	$ 3.66 Billion
Compound Annual Growth Rate	3.9%
Regions Covered	Global
No. of Companies Mentioned	11

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5864EUR$5,950USD£4,870GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6850EUR$6,950USD£5,688GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8821EUR$8,950USD£7,325GBP

Syndromic Multiplex Diagnostics Market Size, Share & Trends Analysis Report By Type (Respiratory, Gastrointestinal, Central Nervous System), By End Use (Hospitals, Diagnostic Laboratories, Others), By Region And Segment Forecasts, 2025 - 2030

Syndromic Multiplex Diagnostics Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

Syndromic Multiplex Diagnostics Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Syndromic Multiplex Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2030

Syndromic Multiplex Diagnostic - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization

Asia-Pacific Acute Care Syndromic Testing Market: Analysis and Forecast, 2023-2033

Acute Care Syndromic Testing Market by Disease Type, Target, Sample Type, End User - Global Forecast 2025-2030